Abstract
Individuals suffering from chronic pain undergo surgical procedures to receive neuromodulation devices, often requiring revision surgery to replace an exhausted battery with a new device. There is a need to eliminate revision surgery with a minimally invasive device. The Injectrode is an injectable electrode designed for rapid placement and removal by a minimally invasive procedure. Here we present data from a non-significant risk clinical trial to assess the safety and function of the Injectrode via a subcutaneously placed gold mesh (BASMATI Injectrode) for 28 days.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Paper Title
Journal
Date
